Blackwell Kimberly 4

What Happened Kimberly Blackwell, a director of Century Therapeutics (IPSC), was granted a derivative award for 74,000 shares on June 11, 2026. The transaction is reported as an award/grant (code A) at $0.00 per share (no cash paid at grant). The award will vest according to the company's vesting schedule (see footnote).

Key Details

• Transaction date: June 11, 2026; Form 4 filed: June 12, 2026 (timely).
• Transaction type/code: Award/Grant (A), derivative instrument reported at $0.00.
• Amount: 74,000 shares granted.
• Vesting: Vests on the earlier of (a) June 11, 2027 or (b) the next annual meeting of stockholders, subject to continued service (footnote).
• Shares owned after transaction: not specified in the provided filing excerpt.
• No sale or open-market purchase occurred—this is a compensation grant.

Context This was a compensation-related derivative grant (likely stock options or RSUs) rather than an open-market buy or sale. Such awards are common for directors and do not by themselves indicate immediate buying or selling in the market; vesting and any later exercise or sale would create reportable transactions in the future.